Account wins from the 10/24/06 News Brief

Share this article:
Porter Novelli subsidiary FischerHealth announced a new client relationship with UltraShape North America developer of Contour I, an ultrasound system for non-invasive body contouring sold outside the US and awaiting marketing approval by the FDA. FischerHealth will represent the client in the US and Canada in conjunction with its parent company, Porter Novelli, which is spearheading UltraShape’s global campaigns.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Researchers hit links for charity

The PMR Charities Golf Classic teed up more than $20,000 for St. Jude Children's Research Hospital.

FDA to review Neupogen biosimilar

Novartis subsidiary Sandoz announced Thursday that the FDA has agreed to review its filgrastim biosimilar which is already approved in 40 countries.

FDA approves a new painkiller

Targiniq ER combines the prescription opioid oxycodone and naloxone, which is often used to treat overdoses.